
|Videos|February 16, 2022
2022 ASCO GU Overview: Dr. Ibilibor on metastatic UC, RCC, and rare cancers
Author(s)Urology Times staff
Christine Ibilibor, MD, discusses 6 noteworthy abstracts from the 2022 Genitourinary Cancers Symposium.
Advertisement
Episodes in this series
In this video, Urology Times® Editorial Council member Christine Ibilbor, MD, discusses abstracts on metastatic urothelial carcinoma, renal cell carcinoma, and rare cancers that will be presented at the 2022 Genitourinary Cancers Symposium. Ibilibor is an assistant professor of urology at the University of Virginia in Charlottesville.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Dosing begins in trial of alpha radioligand therapy for mCRPC
2
Novel tool may help predict early PSA response to ARPIs in mHSPC
3
Fed Ghali, MD, highlights trial of consolidative local therapy following EV/P
4
RCMIGI trial supports feasibility of reduced margins in image-guided prostate radiotherapy
5






















